Relapsed/refractory patients

Ajai Chari | ASCO 2018 | Subgroup analysis of the MMY1001 trial

L:

ASCO Annual Meeting, 1–5 June 2018, Chicago, IL

Ajai Chari
Mount Sinai Hospital, New York, US

Interview topic: Subgroup analysis of the MMY1001 trial to assess daratumumab, carfilzomib, and dexamethasone

Download this article:

You can now download this article in Adobe PDF® format.

Download as PDF